Efficacy and safety of transcatheter left atrial appendage closure guided by transoesophageal echocardiography using standard and micro TEE probes: a single-center retrospective study - Takeaways - MDSpire

Efficacy and safety of transcatheter left atrial appendage closure guided by transoesophageal echocardiography using standard and micro TEE probes: a single-center retrospective study

  • By

  • Alessandro Barbarossa

  • Francesca Coraducci

  • Elisa Nicolini

  • Laura Cipolletta

  • Alessandro Maolo

  • Michela Casella

  • Fabio Vagnarelli

  • Federico Guerra

  • Marco Marini

  • Antonio Dello Russo

  • Tommaso Piva

  • June 9, 2026

  • 0 min

Share

  • 1

    Transcatheter left atrial appendage closure (T-LAAC) is an effective alternative to long-term anticoagulation for patients with atrial fibrillation.

  • 2

    Micro-TEE guidance during T-LAAC resulted in significantly shorter procedural times compared to standard TEE, without increasing complication rates.

  • 3

    Procedural success rates were similar between micro-TEE and standard TEE, with only one failure in the standard TEE group due to device sizing issues.

  • 4

    Micro-TEE was associated with a lower rate of orotracheal intubation, enhancing patient comfort and reducing anesthesia-related risks.

  • 5

    At one-month follow-up, the micro-TEE group did not exhibit an increased complication rate compared to the standard TEE group.

Original Source(s)

Efficacy and safety of transcatheter left atrial appendage closure guided by transoesophageal echocardiography using standard and micro TEE probes: a single-center retrospective study

  • by Alessandro Barbarossa, Francesca Coraducci, Elisa Nicolini, Laura Cipolletta, Alessandro Maolo, Michela Casella, Fabio Vagnarelli, Federico Guerra, Marco Marini, Antonio Dello Russo, Tommaso Piva

  • June 9, 2026

Related Content

Hypertension With High-Risk Features in Cryptogenic Stroke: An Exploratory Analysis of the ARCADIA Randomized

Cognitive outcomes after endovascular thrombectomy in ischemic stroke: a systematic review

Tenecteplase Fails to Boost EVT Outcomes

Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.